APO RESEARCH · REPORT
Pharma & Cosmetics
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.
Product & engineering
Understand the product.
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.
Selected research
Industry Growth & Trends
Global Pharma & Cosmetics Industry Growth and Trends Forecast to 2032
Market perspective
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.
The major players in global Pharma & Cosmetics market include Johnson & Johnson, Roche, Novartis, etc., and the market concentration rate is low. China and Japan are main markets, they occupy about 40% of the global market. Pharmaceuticals, OTC is the main application, which holds a share about 75%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Pharma & Cosmetics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharma & Cosmetics market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma & Cosmetics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma & Cosmetics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pharma & Cosmetics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharma & Cosmetics Market by Company
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L' OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa
Pharma & Cosmetics Segment by Type
Ointments
Creams
Gels
Others
Pharma & Cosmetics Segment by Application
Pharmaceuticals, OTC
Cosmetics
Pharma & Cosmetics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma & Cosmetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma & Cosmetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma & Cosmetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma & Cosmetics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pharma & Cosmetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ointments
- Creams
- Gels
- Others
Applications
- Pharmaceuticals, OTC
- Cosmetics
Companies covered
- Johnson & Johnson
- Roche
- Novartis
- Pfizer
- Sanofi
- Eli Lilly
- GSK
- Bayer
- Merck & Co
- L' OREAL
- Unilever
- Procter & Gamble
- Estee Lauder
- Kao
- Shiseido
- Beiersdorf
- Henkel
- Shanghai Jahwa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pharma & Cosmetics Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pharma & Cosmetics Sales Estimates and Forecasts (2021-2032)
- 1.3 Pharma & Cosmetics Market by Type
- 1.3.1 Ointments
- 1.3.2 Creams
- 1.3.3 Gels
- 1.3.4 Others
- 1.4 Global Pharma & Cosmetics Market Size by Type
- 1.4.1 Global Pharma & Cosmetics Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pharma & Cosmetics Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pharma & Cosmetics Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pharma & Cosmetics Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pharma & Cosmetics Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pharma & Cosmetics Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pharma & Cosmetics Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pharma & Cosmetics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pharma & Cosmetics Industry Trends
- 2.2 Pharma & Cosmetics Industry Drivers
- 2.3 Pharma & Cosmetics Industry Opportunities and Challenges
- 2.4 Pharma & Cosmetics Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pharma & Cosmetics Revenue (2021-2026)
- 3.2 Global Top Players by Pharma & Cosmetics Sales (2021-2026)
- 3.3 Global Top Players by Pharma & Cosmetics Price (2021-2026)
- 3.4 Global Pharma & Cosmetics Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma & Cosmetics Major Company Production Sites & Headquarters
- 3.6 Global Pharma & Cosmetics Company, Product Type & Application
- 3.7 Global Pharma & Cosmetics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharma & Cosmetics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharma & Cosmetics Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharma & Cosmetics Tier 1, Tier 2, and Tier 3
4 Pharma & Cosmetics Regional Status and Outlook
- 4.1 Global Pharma & Cosmetics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pharma & Cosmetics Historic Market Size by Region
- 4.2.1 Global Pharma & Cosmetics Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pharma & Cosmetics Sales in Value by Region (2021-2026)
- 4.2.3 Global Pharma & Cosmetics Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pharma & Cosmetics Forecasted Market Size by Region
- 4.3.1 Global Pharma & Cosmetics Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pharma & Cosmetics Sales in Value by Region (2027-2032)
- 4.3.3 Global Pharma & Cosmetics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma & Cosmetics by Application
- 5.1 Pharma & Cosmetics Market by Application
- 5.1.1 Pharmaceuticals, OTC
- 5.1.2 Cosmetics
- 5.2 Global Pharma & Cosmetics Market Size by Application
- 5.2.1 Global Pharma & Cosmetics Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pharma & Cosmetics Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pharma & Cosmetics Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pharma & Cosmetics Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pharma & Cosmetics Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pharma & Cosmetics Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pharma & Cosmetics Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pharma & Cosmetics Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Johnson & Johnson Pharma & Cosmetics Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Roche Pharma & Cosmetics Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Pharma & Cosmetics Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Pharma & Cosmetics Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Sanofi
- 6.5.1 Sanofi Company Information
- 6.5.2 Sanofi Business Overview
- 6.5.3 Sanofi Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sanofi Pharma & Cosmetics Product Portfolio
- 6.5.5 Sanofi Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Eli Lilly Pharma & Cosmetics Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 GSK
- 6.7.1 GSK Company Information
- 6.7.2 GSK Business Overview
- 6.7.3 GSK Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GSK Pharma & Cosmetics Product Portfolio
- 6.7.5 GSK Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bayer Pharma & Cosmetics Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Merck & Co
- 6.9.1 Merck & Co Company Information
- 6.9.2 Merck & Co Business Overview
- 6.9.3 Merck & Co Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Merck & Co Pharma & Cosmetics Product Portfolio
- 6.9.5 Merck & Co Recent Developments
- 6.10 L' OREAL
- 6.10.1 L' OREAL Company Information
- 6.10.2 L' OREAL Business Overview
- 6.10.3 L' OREAL Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 L' OREAL Pharma & Cosmetics Product Portfolio
- 6.10.5 L' OREAL Recent Developments
- 6.11 Unilever
- 6.11.1 Unilever Company Information
- 6.11.2 Unilever Business Overview
- 6.11.3 Unilever Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Unilever Pharma & Cosmetics Product Portfolio
- 6.11.5 Unilever Recent Developments
- 6.12 Procter & Gamble
- 6.12.1 Procter & Gamble Company Information
- 6.12.2 Procter & Gamble Business Overview
- 6.12.3 Procter & Gamble Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Procter & Gamble Pharma & Cosmetics Product Portfolio
- 6.12.5 Procter & Gamble Recent Developments
- 6.13 Estee Lauder
- 6.13.1 Estee Lauder Company Information
- 6.13.2 Estee Lauder Business Overview
- 6.13.3 Estee Lauder Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Estee Lauder Pharma & Cosmetics Product Portfolio
- 6.13.5 Estee Lauder Recent Developments
- 6.14 Kao
- 6.14.1 Kao Company Information
- 6.14.2 Kao Business Overview
- 6.14.3 Kao Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Kao Pharma & Cosmetics Product Portfolio
- 6.14.5 Kao Recent Developments
- 6.15 Shiseido
- 6.15.1 Shiseido Company Information
- 6.15.2 Shiseido Business Overview
- 6.15.3 Shiseido Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Shiseido Pharma & Cosmetics Product Portfolio
- 6.15.5 Shiseido Recent Developments
- 6.16 Beiersdorf
- 6.16.1 Beiersdorf Company Information
- 6.16.2 Beiersdorf Business Overview
- 6.16.3 Beiersdorf Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Beiersdorf Pharma & Cosmetics Product Portfolio
- 6.16.5 Beiersdorf Recent Developments
- 6.17 Henkel
- 6.17.1 Henkel Company Information
- 6.17.2 Henkel Business Overview
- 6.17.3 Henkel Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Henkel Pharma & Cosmetics Product Portfolio
- 6.17.5 Henkel Recent Developments
- 6.18 Shanghai Jahwa
- 6.18.1 Shanghai Jahwa Company Information
- 6.18.2 Shanghai Jahwa Business Overview
- 6.18.3 Shanghai Jahwa Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Shanghai Jahwa Pharma & Cosmetics Product Portfolio
- 6.18.5 Shanghai Jahwa Recent Developments
7 North America by Country
- 7.1 North America Pharma & Cosmetics Sales by Country
- 7.1.1 North America Pharma & Cosmetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pharma & Cosmetics Sales by Country (2021-2026)
- 7.1.3 North America Pharma & Cosmetics Sales Forecast by Country (2027-2032)
- 7.2 North America Pharma & Cosmetics Market Size by Country
- 7.2.1 North America Pharma & Cosmetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pharma & Cosmetics Market Size by Country (2021-2026)
- 7.2.3 North America Pharma & Cosmetics Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pharma & Cosmetics Sales by Country
- 8.1.1 Europe Pharma & Cosmetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pharma & Cosmetics Sales by Country (2021-2026)
- 8.1.3 Europe Pharma & Cosmetics Sales Forecast by Country (2027-2032)
- 8.2 Europe Pharma & Cosmetics Market Size by Country
- 8.2.1 Europe Pharma & Cosmetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pharma & Cosmetics Market Size by Country (2021-2026)
- 8.2.3 Europe Pharma & Cosmetics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pharma & Cosmetics Sales by Country
- 9.1.1 Asia-Pacific Pharma & Cosmetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pharma & Cosmetics Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pharma & Cosmetics Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pharma & Cosmetics Market Size by Country
- 9.2.1 Asia-Pacific Pharma & Cosmetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pharma & Cosmetics Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pharma & Cosmetics Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pharma & Cosmetics Sales by Country
- 10.1.1 South America Pharma & Cosmetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pharma & Cosmetics Sales by Country (2021-2026)
- 10.1.3 South America Pharma & Cosmetics Sales Forecast by Country (2027-2032)
- 10.2 South America Pharma & Cosmetics Market Size by Country
- 10.2.1 South America Pharma & Cosmetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pharma & Cosmetics Market Size by Country (2021-2026)
- 10.2.3 South America Pharma & Cosmetics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pharma & Cosmetics Sales by Country
- 11.1.1 Middle East and Africa Pharma & Cosmetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pharma & Cosmetics Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pharma & Cosmetics Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pharma & Cosmetics Market Size by Country
- 11.2.1 Middle East and Africa Pharma & Cosmetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pharma & Cosmetics Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pharma & Cosmetics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pharma & Cosmetics Value Chain Analysis
- 12.1.1 Pharma & Cosmetics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pharma & Cosmetics Production Mode & Process
- 12.2 Pharma & Cosmetics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pharma & Cosmetics Distributors
- 12.2.3 Pharma & Cosmetics Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst